Flavomycin - 8% premix
CAS: 11015-37-5
Ref. 3D-AF145529
10g | 136.00 € | ||
25g | 192.00 € | ||
50g | 270.00 € | ||
100g | 407.00 € | ||
250g | 544.00 € |
Product Information
- BambermycinMoenomycin
- (2R)-3-{[{[(2R,3R,4R,5S,6S)-3-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-4-hydroxy-6-methyl-5-({(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)carbamoyl]tetrahydro-2H-pyran-2-yl}oxy)tetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}methyl)tetrahydro-2H-pyran-2-yl]oxy}-6-carbamoyl-4-(carbamoyloxy)-5-hydroxy-5-methyltetrahydro-2H-pyran-2-yl]oxy}(hydroxy)phosphoryl]oxy}-2-{[(2Z,6E,13E)-3,8,8,14,18-pentamethyl-11-methylidenenonadeca-2,6,13,17-tetraen-1-yl]oxy}propanoic acid (non-preferred name)
- (2S,3S,4R,5R,6R)-5-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-4-hydroxy-6-methyl-5-({(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)carbamoyl]tetrahydro-2H-pyran-2-yl}oxy)tetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}methyl)tetrahydro-2H-pyran-2-yl]oxy}-4-(carbamoyloxy)-6-({[(2R)-2-carboxy-2-{[(2E,6E,13E)-3,8,8,14,18-pentamethyl-11-methylidenenonadeca-2,6,13,17-tetraen-1-yl]oxy}ethoxy](hydroxy)phosphoryl}oxy)-3-hydroxy-3-methyltetrahydro-2H-pyran-2-carboxylic acid (non-preferred name)
- Flapol
- Flavofosfolipol
- Flavomycin
- Flavophospholipol
- Gainpro
- Menomycin
- Moenomycin
- See more synonyms
- Pharmastim
- Bambermycin
Flavomycin is an antibiotic that belongs to the group of aminoglycosides. It inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, inhibiting the binding of aminoacyl-tRNA to the A site. Flavomycin has been shown to be active against a range of human pathogens, including Mycobacterium tuberculosis and Salmonella enterica serovar Typhi. Flavomycin acts by binding to the penicillin-binding protein (PBP) in bacterial cells. This prevents peptidyl transferase from linking amino acids together in the formation of proteins, resulting in inhibition of cell growth and eventual cell death.
Flavomycin has been shown to have a high degree of structural similarity with other antimicrobial agents such as amoxicillin-clavulanic acid and salinomycin sodium, which may indicate its potential as a model system for these drugs. Structural analysis has revealed that flavomycin binds
Chemical properties
Technical inquiry about: 3D-AF145529 Flavomycin - 8% premix
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.